Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2009 1
2010 2
2015 4
2017 2
2018 3
2019 4
2020 6
2021 3
2022 6
2023 3
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida H, Stewart J, Kabashima K; XCIMA Study Group. Ruzicka T, et al. N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490. N Engl J Med. 2017. PMID: 28249150 Free article. Clinical Trial.
Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems.
Castillo RL, Sidhu I, Dolgalev I, Chu T, Prystupa A, Subudhi I, Yan D, Konieczny P, Hsieh B, Haberman RH, Selvaraj S, Shiomi T, Medina R, Girija PV, Heguy A, Loomis CA, Chiriboga L, Ritchlin C, Garcia-Hernandez ML, Carucci J, Meehan SA, Neimann AL, Gudjonsson JE, Scher JU, Naik S. Castillo RL, et al. Among authors: neimann al. Sci Immunol. 2023 Jun 8;8(84):eabq7991. doi: 10.1126/sciimmunol.abq7991. Epub 2023 Jun 2. Sci Immunol. 2023. PMID: 37267384 Free PMC article.
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman RH, MacFarlane KA, Catron S, Samuels J, Blank RB, Toprover M, Uddin Z, Hu J, Castillo R, Gong C, Qian K, Piguet V, Tausk F, Yeung J, Neimann AL, Gulliver W, Thiele RG, Merola JF, Ogdie A, Rahman P, Chakravarty SD, Eder L, Ritchlin CT, Scher JU. Haberman RH, et al. Among authors: neimann al. BMJ Open. 2022 Dec 23;12(12):e063650. doi: 10.1136/bmjopen-2022-063650. BMJ Open. 2022. PMID: 36564123 Free PMC article.
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study.
Webster DE, Haberman RH, Perez-Chada LM, Tummalacherla M, Tediarjo A, Yadav V, Neto EC, MacDuffie W, DePhillips M, Sieg E, Catron S, Grant C, Francis W, Nguyen M, Yussuff M, Castillo RL, Yan D, Neimann AL, Reddy SM, Ogdie A, Kolivras A, Kellen MR, Mangravite LM, Sieberts SK, Omberg L, Merola JF, Scher JU. Webster DE, et al. Among authors: neimann al. J Rheumatol. 2024 Aug 1;51(8):781-789. doi: 10.3899/jrheum.2024-0074. J Rheumatol. 2024. PMID: 38879192
A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation.
Garshick MS, Drenkova K, Barrett TJ, Schlamp F, Fisher EA, Katz S, Jelic S, Neimann AL, Scher JU, Krueger J, Berger JS. Garshick MS, et al. Among authors: neimann al. J Invest Dermatol. 2022 Jun;142(6):1749-1752.e4. doi: 10.1016/j.jid.2021.07.190. Epub 2021 Nov 19. J Invest Dermatol. 2022. PMID: 34808233 Free PMC article. Clinical Trial. No abstract available.
GRAPPA 2020 Research Award Recipients.
Castillo RL, Yan D, Ashhurst AS, Elliott A, Angioni MM, Scher JU, Naik S, Neimann A, Byrne SN, Payne RJ, FitzGerald O, Pennington SR, Cauli A, Chandran V. Castillo RL, et al. Among authors: neimann a. J Rheumatol. 2022 Jun;49(6 Suppl 1):55-56. doi: 10.3899/jrheum.211335. Epub 2022 Mar 15. J Rheumatol. 2022. PMID: 35293338 Free PMC article.
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, Weinberg JM, Kircik L, Han G, Langley RG, Neimann AL, Lebwohl M. Burshtein J, et al. Among authors: neimann al. J Drugs Dermatol. 2024 Aug 1;23(8):592-599. doi: 10.36849/JDD.8246. J Drugs Dermatol. 2024. PMID: 39093660 Review.
COVID-19 outcomes in patients with psoriasis and psoriatic arthritis: A prospective cohort study.
Yan D, Kolla AM, Young T, Fried L, Shankar S, Rangel L, Yin L, Castillo R, Steuer A, Svigos K, Izmirly P, Sekar V, Lesser R, Solomon G, Blank RB, Haberman RH, Neimann AL, Scher JU. Yan D, et al. Among authors: neimann al. JAAD Int. 2022 Sep;8:31-33. doi: 10.1016/j.jdin.2022.03.011. Epub 2022 Mar 28. JAAD Int. 2022. PMID: 35373153 Free PMC article. No abstract available.
Reply: To PMID 25319745.
Scher JU, Reddy S, Ubeda C, Neimann A, Abramson SB. Scher JU, et al. Among authors: neimann a. Arthritis Rheumatol. 2015 May;67(8):2280-2. doi: 10.1002/art.39152. Arthritis Rheumatol. 2015. PMID: 25891517 Free PMC article. No abstract available.
36 results